0001144204-14-044298.txt : 20140722
0001144204-14-044298.hdr.sgml : 20140722
20140722212652
ACCESSION NUMBER: 0001144204-14-044298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140718
FILED AS OF DATE: 20140722
DATE AS OF CHANGE: 20140722
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLASE, INC
CENTRAL INDEX KEY: 0000811240
STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843]
IRS NUMBER: 870442441
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 CROMWELL
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-361-1200
MAIL ADDRESS:
STREET 1: 4 CROMWELL
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLASE TECHNOLOGY INC
DATE OF NAME CHANGE: 19941117
FORMER COMPANY:
FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC
DATE OF NAME CHANGE: 19941117
FORMER COMPANY:
FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP
DATE OF NAME CHANGE: 19920708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FEINBERG LARRY N
CENTRAL INDEX KEY: 0000926475
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36385
FILM NUMBER: 14987564
MAIL ADDRESS:
STREET 1: C/O ORACLE PARTNERS L P
STREET 2: 200 GREENWICH AVENUE
CITY: GREENWICH
STATE: CT
ZIP: 06830
4
1
v384456_4.xml
OWNERSHIP DOCUMENT
X0306
4
2014-07-18
0
0000811240
BIOLASE, INC
BIOL
0000926475
FEINBERG LARRY N
200 GREENWICH AVENUE
GREENWICH
CT
06830
0
0
1
0
Common Stock, par value $0.001 per share
2014-07-18
4
P
0
369044
1.92
A
1686550
I
See footnote
Common Stock, par value $0.001 per share
2014-07-18
4
P
0
1641036
1.92
A
5857251
I
See footnote
Common Stock, par value $0.001 per share
2014-07-18
4
P
0
260756
1.92
A
862945
I
See footnote
These securities are owned by Oracle Ten Fund Master, L.P. ("Ten Fund").
These securities are owned by Oracle Partners, L.P. ("Partners").
These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners").
The Reporting Person serves as the managing member of Oracle Associates, LLC, the general partner of Partners and Institutional Partners, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners and Institutional Partners. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Ten Fund. Mr. Feinberg disclaims beneficial ownership of all such shares except to the extent of his pecuniary interest therein.
On March 5, 2014, Biolase, Inc. declared a one-half percent stock dividend payable on March 28, 2014 to all stockholders of record on March 14, 2014. As a result, on March 28, 2014 Ten Fund received 6,554 shares of common stock, Partners received 20,976 shares of common stock, and Institutional Partners received 2,994 shares of common stock.
/s/ Larry N. Feinberg
2014-07-22